- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
PTEN protein loss by immunostaining: Analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients - Abstract
September 22, 2011
Evolution of the clinical presentation of men undergoing radical prostatectomy for high-risk prostate cancer - Abstract
September 22, 2011
Locally advanced cervical cancer: Should intensity-modulated radiotherapy replace brachytherapy? - Abstract
September 22, 2011
American College of Radiology Appropriateness Criteria(®) - locally advanced (high-risk) prostate cancer - Abstract
September 21, 2011
Cost effectiveness of chemoprevention for prostate cancer with dutasteride in a high-risk population based on results from the REDUCE clinical trial - Abstract
September 21, 2011
An internet intervention for management of uncertainty during active surveillance for prostate cancer - Abstract
September 21, 2011
New role for an established drug? Bisphosphonates as potential anticancer agents - Abstract
September 21, 2011
Social and clinical predictors of prostate cancer treatment decisions among men in South Carolina - Abstract
September 21, 2011
Imatinib mesylate (Gleevec) as protein-tyrosine kinase inhibitor elicits smooth muscle relaxation in isolated human prostatic tissue - Abstract
September 21, 2011
Contemporary role of prostate cancer antigen 3 in the management of prostate cancer - Abstract
September 20, 2011
Seminal vesicle biopsies: Interest in the prostate cancer staging before radiation therapy or brachytherapy - Abstract
September 20, 2011
Low risk prostate cancer in men ≥ 70 years old: To treat or not to treat - Abstract
September 20, 2011